Table 15Proportions of patients on different Lipid-lowering drugs data provided by Dr Dalya Marks (personal communication)

Drug% (proportions on the drug)*
Atorvastatin 40mg30%
Atorvastatin 40mg + ezetimibe30%
Atorvastatin 80mg10%
Atorvastatin 80mg + ezetimibe10%
Simvastatin 40mg5%
Simvastatin 40mg+ ezetimibe5%
Simvastatin 80mg5%
Simvastatin 80mg+ ezetimibe5%

From: Appendix E, Health Economic modelling

Cover of Identification and Management of Familial Hypercholesterolaemia (FH)
Identification and Management of Familial Hypercholesterolaemia (FH) [Internet].
NICE Clinical Guidelines, No. 71.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.